TN-001 eyedrops for progressive keratoconus
Part of Eyes & vision clinical trials.
This trial tests a new eyedrop (TN-001) for people with keratoconus that is getting worse. The drops are applied twice a day to try to stop the cornea from thinning and bulging further.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- You have keratoconus that is getting worse (progressive).
- Your cornea is at least as thick as a credit card (400 microns).
- You are not currently using contact lenses or other eye drops for dry eyes.
- You have not had any previous eye surgeries or procedures like corneal cross-linking.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an eye drop called GLK-221 for people with keratoconus, a condition where the clear front of the eye bulges. The goal is to see if the drops can safely help improve the condition compared to a placebo (an inactive solution).
This study tests a lab-grown (ex vivo) method of strengthening donor cornea tissue used in cornea transplants for people with keratoconus. It may help improve how well the transplanted cornea heals and functions.
This trial compares two ways to manage inflammation after corneal crosslinking for keratoconus: a tiny steroid insert placed in the tear duct versus standard steroid eye drops. It aims to see which option is easier and works just as well.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This trial tests whether prescription inserts placed in the cornea can improve day-to-day vision for people with keratoconus whose vision is getting worse and who have few options left. You may be able to avoid or delay corneal transplant depending on your cornea shape and thickness.
This study looks at what leads to keratoconus and how it progresses over time. It may help doctors better predict worsening vision and plan earlier care.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.